Narwhal Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8M | Buy |
25,376
+3,845
| +18% | +$3M | 1.59% | 14 |
|
|
2025
Q1 | $17.8M | Sell |
21,531
-925
| -4% | -$764K | 1.58% | 15 |
|
|
2024
Q4 | $17.3M | Buy |
22,456
+1,053
| +5% | +$813K | 1.53% | 15 |
|
|
2024
Q3 | $19M | Buy |
21,403
+3,407
| +19% | +$3.02M | 1.71% | 13 |
|
|
2024
Q2 | $16.3M | Buy |
17,996
+1,821
| +11% | +$1.65M | 1.54% | 17 |
|
|
2024
Q1 | $12.6M | Sell |
16,175
-2,764
| -15% | -$2.15M | 1.23% | 21 |
|
|
2023
Q4 | $11M | Sell |
18,939
-632
| -3% | -$368K | 1.21% | 21 |
|
|
2023
Q3 | $10.5M | Sell |
19,571
-2,500
| -11% | -$1.34M | 1.28% | 21 |
|
|
2023
Q2 | $10.4M | Sell |
22,071
-3,935
| -15% | -$1.85M | 1.22% | 23 |
|
|
2023
Q1 | $8.93M | Buy |
26,006
+5,675
| +28% | +$1.95M | 1.12% | 29 |
|
|
2022
Q4 | $7.44M | Buy |
20,331
+3,133
| +18% | +$1.15M | 0.99% | 34 |
|
|
2022
Q3 | $5.56M | Buy |
17,198
+16,340
| +1,904% | +$5.28M | 0.81% | 39 |
|
|
2022
Q2 | $278K | Hold |
858
| – | – | 0.04% | 131 |
|
|
2022
Q1 | $246K | Sell |
858
-230
| -21% | -$65.9K | 0.03% | 133 |
|
|
2021
Q4 | $301K | Sell |
1,088
-154
| -12% | -$42.6K | 0.03% | 128 |
|
|
2021
Q3 | $287K | Hold |
1,242
| – | – | 0.04% | 129 |
|
|
2021
Q2 | $285K | Buy |
+1,242
| New | +$285K | 0.04% | 132 |
|
|
2014
Q1 | – | Sell |
-10,500
| Closed | -$535K | – | 138 |
|
|
2013
Q4 | $535K | Sell |
10,500
-1,000
| -9% | -$51K | 0.22% | 111 |
|
|
2013
Q3 | $579K | Buy |
11,500
+1,000
| +10% | +$50.3K | 0.28% | 105 |
|
|
2013
Q2 | $516K | Buy |
+10,500
| New | +$516K | 0.25% | 105 |
|